↓ Skip to main content

Cochrane Database of Systematic Reviews

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Overview of attention for article published in Cochrane database of systematic reviews, February 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
32 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
38 Mendeley
Title
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis
Published in
Cochrane database of systematic reviews, February 2021
DOI 10.1002/14651858.cd009593.pub5
Pubmed ID
Authors

Jerry S Zifodya, Jonah S Kreniske, Ian Schiller, Mikashmi Kohli, Nandini Dendukuri, Samuel G Schumacher, Eleanor A Ochodo, Frederick Haraka, Alice A Zwerling, Madhukar Pai, Karen R Steingart, David J Horne

Twitter Demographics

The data shown below were collected from the profiles of 32 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 16%
Student > Master 5 13%
Student > Bachelor 4 11%
Student > Postgraduate 3 8%
Researcher 3 8%
Other 7 18%
Unknown 10 26%
Readers by discipline Count As %
Medicine and Dentistry 10 26%
Immunology and Microbiology 3 8%
Social Sciences 3 8%
Nursing and Health Professions 2 5%
Environmental Science 1 3%
Other 7 18%
Unknown 12 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2021.
All research outputs
#1,221,982
of 17,961,888 outputs
Outputs from Cochrane database of systematic reviews
#3,112
of 11,791 outputs
Outputs of similar age
#33,733
of 305,474 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 45 outputs
Altmetric has tracked 17,961,888 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,791 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,474 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.